Arrhythmias & electrophysiology

Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care: Post Hoc Analysis of the LOOP Randomized Clinical Trial

JAMA CardiolPublished Secondary analysis of the LOOP randomised trial

Primary result · Bradyarrhythmia diagnosedResult — go to the resultHazard ratio 6.21 95% CI 5.15–7.48

Authors' conclusion

In this study, ILR screening led to a 6-fold increase in bradyarrhythmia diagnoses and a significant increase in pacemaker implantations compared with usual care but no change in the risk of syncope or sudden death.

Study context

Population
Persons aged ≥70 years without known atrial fibrillation (AF) with ≥1 of hypertension, DM, HF or prior stroke, 4 sites in Denmark
Participants
6,004 persons
Comparison
Implantable loop recorder (ILR) screening for AF vs usual care
  • ILRn = 1,501
  • Controln = 4,503reference
Primary endpoint
Adjudicated bradyarrhythmia episodes, pacemaker implantation, syncope and sudden CV death
Follow-up
Median 65 (IQR 59-70) months
Methodological detailspost hoc analysis, multicentre
  • Post hoc analysis
  • Multicentre

Primary result

Bradyarrhythmia diagnosed

Hazard ratio

6.21

95% CI 5.15–7.48

P < 0.001

Events by treatment group

ILRvs Control
HR 6.21 (95% CI 5.15–7.48); P < 0.001

As reported in the abstract

Further findings

OutcomeILRControlHR (95% CI)P value
Pacemaker implantation4.5%2.9%1.53 (1.14–2.06)P < 0.001
Syncope2.2%2.7%0.83 (0.56–1.22)P = 0.34
Sudden CV death1.2%1.1%1.11 (0.64–1.90)P = 0.71

Risk factors and prognosis of bradyarrhythmia

Risk factors: higher age, male sex, prior syncope
Bradyarrhythmias associated with subsequent syncope, CV death and all-cause death; no interaction with randomisation group

Original publication

Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care: Post Hoc Analysis of the LOOP Randomized Clinical Trial. JAMA Cardiol. Published 1 April 2023. doi:10.1001/jamacardio.2022.5526

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.